OVOL1 and Alzheimer disease: Activation of AhR by specific ligands, such as 6-formylindolo(3,2-b)carbazole (FICZ) and glyteer, has been shown to upregulate OVOL1 and subsequently increase FLG expression, which is often reduced in patients with AD [34].